Title:Assessing the Frequency of COVID-19 in Patients Undergoing Primary
Percutaneous Coronary Intervention (PCI)
Volume: 23
Issue: 3
Author(s): Mahdi Zahedi*Faezeh Davanloo
Affiliation:
- Department of Cardiology, School of Medicine, Sayyad Shirazi Hospital, Golestan University of Medical Sciences,
Gorgan, Iran
Keywords:
COVID-19, PCI, MI, diabetes, cardiovascular disease, acute respiratory syndrome.
Abstract:
Background: The COVID-19 pandemic, caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has become a global health crisis with significant morbidity
and mortality.
Objective: The aim of this study was to investigate the incidence of COVID-19 in patients undergoing
primary percutaneous coronary intervention (PCI) for myocardial infarction and identify
associated demographic and clinical characteristics.
Methods: In this study, a retrospective and descriptive cross-sectional design was used to examine
all patients (a total of 85) who experienced acute myocardial infarction and underwent primary
percutaneous coronary intervention (PCI). The study measured various parameters, such as
COVID-19 status, age, sex, ethnicity, diabetes, and hypertension. Data analysis was conducted
using SPSS version 25 software.
Results: Out of the 85 patients who underwent primary percutaneous coronary intervention
(PCI) for myocardial infarction (MI), 14 patients (16.5%) were found to have COVID-19.
COVID-19 diagnosis was confirmed through RT-PCR testing for 2 patients, while the remaining
12 patients were diagnosed using lung CT scans. Among the COVID-19 patients, 21.4% (n = 3)
had background diabetes, and 7.1% (n = 1) had background hypertension. MI recurrence was
observed in 14.3% of COVID-19 patients (2 cases). Unfortunately, 1 COVID-19 patient, a 70-
year-old Persian woman with diabetes and hypertension, passed away. No significant differences
were found in terms of age, sex, ethnicity, underlying diabetes, or underlying hypertension between
the COVID-19 and non-COVID-19 groups.
Conclusion: The high occurrence of COVID-19 among myocardial infarction (MI) patients undergoing
primary percutaneous coronary intervention (PCI) is worth noting. Further investigation
is recommended to explore the impact of demographic and contextual factors on the severity
and outcomes of primary PCI in MI patients with COVID-19, as well as the underlying mechanisms
involved.
